A declaration signed by 85 companies, including pharmaceutical, generics and diagnostics firms, as well as nine industry associations, calls on governments and industry to work together to address the threat of drug-resistant infections. The statement, launched Thursday at the World Economic Forum in Davos, aims to set out for the first time how parties need to work in partnership to support sustained investment to tackle rising drug resistance.

This website uses cookies to improve your experience. We use cookies to help give you the best experience on our website. By continuing without changing your cookie settings, we assume you agree to this. You can opt-out if you wish, see read more for instruction how to do this.AcceptRead More